Our mRNA expression analysis data showed that the expression of CD133, CD44, and SOX2 established CSC markers in CRC, which were altered because of PYCR2 loss, thus supporting the assumption that PYCR2 expression may cause the CSC niche to promote CRC aggressiveness. Here, PYCR2 is linked to colorectal carcinoma.